Creek Drive Management Group’s Palisade Bio PALI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$920K Sell
440,000
-100,000
-19% -$197K 0.45% 38
2026
Q1
$945K Buy
540,000
+232,500
+76% +$423K 0.22% 44
2025
Q4
$723K Buy
+307,500
New +$591K 0.17% 40

Other funds holding PALI

Creek Drive Management Group's PALI Position: Q2 2026 in Review

Creek Drive Management Group reduced its Palisade Bio (PALI) stake by 19% in Q2 2026, selling an estimated $197K and leaving 440,000 shares worth $920K. The position accounts for 0.45% of the portfolio, ranked #38.

Creek Drive Management Group first reported a position in PALI in Q4 2025 and has held it in 3 quarters since. The position peaked at $945K in Q1 2026. 124 funds tracked by Wall St. Rank hold PALI as of Q2 2026.

  • Creek Drive Management Group held 440,000 shares of Palisade Bio worth $920K as of Q2 2026.
  • Creek Drive Management Group sold 100,000 Palisade Bio shares in Q2 2026, an estimated $197K.
  • Palisade Bio made up 0.45% of Creek Drive Management Group's portfolio in Q2 2026, its #38 holding.
  • Creek Drive Management Group first reported a position in Palisade Bio in Q4 2025 and has held it in 3 quarters since.
  • Creek Drive Management Group's Palisade Bio position peaked at $945K in Q1 2026.
  • 124 funds tracked by Wall St. Rank held Palisade Bio as of Q2 2026.

Based on Creek Drive Management Group's 13F filing for Q2 2026, filed 13 Aug 2026.